OYST - Oyster Point Pharma GAAP EPS of -$1.37 misses by $0.11 revenue of $5.59M misses by $8.72M November, 14 2022 01:43 PM Oyster Point Pharma Inc. Oyster Point Pharma press release ( NASDAQ: OYST ): Q3 GAAP EPS of -$1.37 misses by $0.11 . Revenue of $5.59M (-68.8% Y/Y) misses by $8.72M . For further details see: Oyster Point Pharma GAAP EPS of -$1.37 misses by $0.11, revenue of $5.59M misses by $8.72M